Skip to main content
C-RAD logo

C-RAD — Investor Relations & Filings

Ticker · CRAD ISIN · SE0002016352 LEI · 549300SPXLHF15W2CU25 ST Manufacturing
Filings indexed 532 across all filing types
Latest filing 2023-09-25 Major Shareholding Noti…
Country SE Sweden
Listing ST CRAD

About C-RAD

https://c-rad.com/

C-RAD is a medical technology company that develops and supplies solutions for advanced radiation therapy. The company's core offering is its Surface Guided Radiation Therapy (SGRT) technology, which provides high-precision patient positioning, real-time intra-fractional motion management, and respiratory gating. These systems are designed to increase treatment accuracy, enhance patient safety, and improve workflow efficiency in radiation oncology clinics. C-RAD's product portfolio also includes solutions for tumor localization and workflow automation, aiming to help clinicians deliver effective radiotherapy treatments, improve clinical outcomes, and enhance the quality of life for cancer patients.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for 'Nordnet AB (publ)' in 'C-Rad AB'. Specifically, it shows the 'Before the transaction' and 'After the transaction' share counts, the 'Reason for major shareholding notification Sell', and the resulting percentage (4.99545% directly held shares, 4.06139% voting rights). This structure is characteristic of a notification regarding a change in significant ownership, which corresponds to the Major Shareholding Notification category.
2023-09-25 English
Partnership agreement at a value of 10 MSEK signed between C-RAD and Katholisches Klinikum Bochum
Regulatory Filings Classification · 1% confidence The document announces a specific business event: the signing of a partnership agreement valued at 10 MSEK between C-RAD and a German hospital. It includes quotes from management, details about the contract scope (software, service), and is dated September 15, 2023. Crucially, the final paragraph states: "This information is information that C-Rad is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly suggests a mandatory regulatory disclosure concerning a significant contract, which is not a standard financial report (10-K, IR, ER) or a shareholder vote material (AGM-R, DEF 14A). Since it is a specific, material announcement required by regulation (MAR), and it doesn't fit the definitions for Capital/Financing (CAP), M&A (TAR), or Director's Dealing (DIRS), the most appropriate general category for mandatory regulatory disclosures that aren't explicitly defined elsewhere is Regulatory Filings (RNS). It is not an announcement of a report publication (RPA) because it *is* the substantive announcement itself, not just a notice that a report is coming.
2023-09-15 English
C-RAD och Katholisches Klinikum Bochum tecknar partnerskapsavtal värt 10 MSEK
Regulatory Filings Classification · 1% confidence The document is a press release dated September 15, 2023, announcing a partnership agreement and order worth 10 MSEK between C-RAD and Katholisches Klinikum Bochum for surface scanning technology in radiation therapy. It includes quotes from management, details about the technology, and contact information for investors and press. Crucially, the end of the document states, "Denna information är sådan information som C-Rad är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such information that C-Rad is obliged to disclose pursuant to the EU Market Abuse Regulation) and it is explicitly labeled as a "Pressmeddelande" (Press Release). Since it is an announcement of a significant business event and is not a comprehensive periodic report (like 10-K or IR) or a specific regulatory filing like insider trading (DIRS) or capital change (SHA), it falls best under the general category for regulatory announcements or miscellaneous filings that are market-sensitive. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a mandatory market disclosure that isn't covered by a more specific code like ER (Earnings Release) or CAP (Financing Update). The document length is short (under 5,000 characters) and it announces information rather than being the full report itself, but RNS is used for general regulatory announcements.
2023-09-15 Swedish
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding and voting rights for Nordnet AB (publ) concerning C-Rad AB. Specifically, it shows the 'Before the transaction' and 'After the transaction' share counts, resulting in a new percentage of voting rights (4.08102%). The note explicitly states that a threshold value was crossed ('har överskridit tröskelvärde genom nettoköp'). This type of filing, reporting changes in significant share ownership that cross predefined thresholds, corresponds directly to the Major Shareholding Notification category.
2023-08-29 English
Återköp av C-RAD B-aktier i vecka 34, 2023
Transaction in Own Shares Classification · 1% confidence The document is a press release dated August 28, 2023, detailing the repurchase of the company's own B-shares ('Återköp av C-RAD B-aktier') during the previous week. It provides specific transaction volumes, weighted average prices, and the resulting total holding of treasury shares. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The code for this is POS.
2023-08-28 Swedish
Repurchase of C-RAD B-shares in week 34, 2023
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Repurchase of C-RAD B-shares' conducted between August 21 and August 23, 2023, including the number of shares, weighted average price, and total value. This activity directly relates to the company buying back its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (Code: POS). The document length is short (3147 chars), but it contains the full details of the transaction rather than just announcing that a report is attached, making POS a more specific fit than RPA or RNS.
2023-08-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.